Amid rising concerns about autonomous driving technologies, Morgan Stanley analyst Brian Nowak maintains an Overweight rating on Uber with a bullish $90 price target. Highlighting Uber's lower growth-adjusted multiple compared to competitors, Nowak underscores the potential for significant upside, driven by robust multi-product strategies and expanding market opportunities, especially in the face of competitors like Lyft and Maplebear.
Reddit (RDDT) is set to report its Q1 earnings on Tuesday. Wall Street analysts are optimistic about the report, though valuation makes one take a pause.
Johnson & Johnson's results in treating bladder and prostate cancer. Learn about TAR-210's efficacy in high-risk NMIBC patients and TAR-200's promising outcomes for BCG-unresponsive cases.